How PayPal and Synchrony Are Further Strengthening Their Partnership
PayPal and Synchrony Financial took a step forward in their relationship and announced that they had closed their consumer credit receivables transaction.
All Work
Chris Lange
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a mixed day for the broad U.S. markets, with only one of the major exchanges making any real headway. Crude oil finally broke its winning streak and remained flat on the day.…
Why Nuvectra Is Monday’s Big Biotech Loser
Nuvectra shares were crushed on Monday after the company announced an update on its FDA premarket approval application and its TÜV SÜD application for CE Mark in Europe for Virtis.
Berry Petroleum Files for IPO
Independent upstream energy company Berry Petroleum has filed with the SEC regarding its initial public offering.
FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date
Merck shares retreated to start off the week despite the announcement of good news from the FDA.
Adamis and Novartis Team Up Against Mylan
Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of Novartis.
Biopharma Companies to Watch This Week
Here are a few biotech and pharmaceutical companies to watch for in the coming week and for the month of July.
Massive Biopharma Movers of the Past Week
A few biopharma stocks made massive runs over the course of this past week, some losing more than half their cap. Not all these moves were negative, but the overall sentiment was negative.
Friday’s Biggest Winners and Losers in the S&P 500
Friday was a positive day for the broad U.S. markets, closing out what was a week full of ups and downs. Crude oil again pushed much higher in the session, for its fourth consecutive…
Acceleron Pharma and Celgene Knock It Out of the Park in Late-Stage Trial
Acceleron Pharma and Celgene each saw gains on Friday after they reported results from a late-stage trial.
Dermira Wins Big on FDA Approval
Dermira shares made a solid gain to close out the week after the firm announced a key approval from the FDA for Qbrexza (glycopyrronium) cloth.
Why Gemphire Therapeutics Shares More Than Doubled
Gemphire Therapeutics shares more than doubled early on Thursday after the company announced results from a midstage trial for severe hypertriglyceridemia.
How Nike Powered Through Q4
Nike shares rose after it released better-than-expected fiscal fourth-quarter financial results after the markets closed on Thursday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday started out as another down day for the broad U.S. markets but ultimately ended positive. Crude oil again pushed much higher in the session, for its third consecutive day. The S&P 500 sectors…
Will Shrinkage Translate to Growth for Chipotle?
Chipotle Mexican Grill shares sank on Thursday after the burrito chain announced that it would be instigating a few changes to drive the brand forward.
BJ’s Enters the Market With a Bang in IPO
BJ’s Wholesale Club entered the market with a bang in its initial public offering.
Kroger Enlists Autonomous Delivery Service in Fight Against Amazon
In an effort to fight against Amazon, The Kroger Co. (NYSE: KR) is enlisting the aid of Nuro for a fully autonomous delivery service. The test for this delivery service is not scheduled until…
BrightView Quietly Enters the Market in IPO
BrightView entered the market quietly in its initial public offering (IPO). The stock entered the market with a slight gain compared to the pricing but quickly fell flat.
What to Expect When Nike Reports
Nike is scheduled to release its fiscal fourth-quarter financial results after the markets close on Thursday, and some analysts have high expectations.
Why Arsanis Shares Are Bombing
Arsanis shares were absolutely crushed on Thursday after the company provided an update from its midstage trial. The company decided that it will cut and run, ultimately discontinuing its pneumonia trial.